These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 27964751)

  • 1. Neurotoxicity and nephrotoxicity caused by combined use of lithium and risperidone: a case report and literature review.
    Hsu CW; Lee Y; Lee CY; Lin PY
    BMC Pharmacol Toxicol; 2016 Dec; 17(1):59. PubMed ID: 27964751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Encephalopathy with combined lithium-risperidone administration.
    Boora K; Xu J; Hyatt J
    Acta Psychiatr Scand; 2008 May; 117(5):394-5; discussion 396. PubMed ID: 18331580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of atypical antipsychotics in Charles Perrens psychiatric hospital (Bordeaux) analysis of prescribing practices for Amisulpride, Clozapine, Olanzapine and Risperidone].
    Bret P; Bonnet F; Bret MC; Jaffré A
    Encephale; 2002; 28(4):329-42. PubMed ID: 12232542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lithium-neuroleptic neurotoxicity in the elderly bipolar patient.
    Miller F; Menninger J; Whitcup SM
    J Clin Psychopharmacol; 1986 Jun; 6(3):176-8. PubMed ID: 2872237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neurotoxicity related to lithium-risperidon combination treatment in a patient with schizoaffective disorder].
    Böker H; Brandenberger M; Schopper C
    Psychiatr Prax; 2007 Jan; 34(1):38-41. PubMed ID: 17106843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatic tolerance of atypical antipsychotic drugs].
    Dumortier G; Cabaret W; Stamatiadis L; Saba G; Benadhira R; Rocamora JF; Aubriot-Delmas B; Glikman J; Januel D
    Encephale; 2002; 28(6 Pt 1):542-51. PubMed ID: 12506267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic malignant syndrome associated with risperidone and olanzapine in first-episode schizophrenia.
    Aboraya A; Schumacher J; Abdalla E; LePage J; McGhee M; Butcher D; Griffin H; Shahda M
    W V Med J; 2002; 98(2):63-5. PubMed ID: 12048741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risperidone-induced marked elevation of serum creatine kinase in adolescence. A case report.
    Holtmann M; Meyer AE; Pitzer M; Schmidt MH
    Pharmacopsychiatry; 2003 Nov; 36(6):317-8. PubMed ID: 14663658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Risperidone after clozapine in therapy refractory schizoaffective psychosis--a case report].
    Konrad C; Schormair C; Eikelmann B; Telger K
    Psychiatr Prax; 1997 Mar; 24(2):88-9. PubMed ID: 9190618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe psychotic exacerbation during combined treatment with aripiprazole/haloperidol after prior treatment with risperidone.
    Letmaier M; Painold A; Holl AK; Grohmann R; Vergin H
    Int J Psychiatry Clin Pract; 2012 Jun; 16(2):153-6. PubMed ID: 22211772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety.
    Sachs GS; Grossman F; Ghaemi SN; Okamoto A; Bowden CL
    Am J Psychiatry; 2002 Jul; 159(7):1146-54. PubMed ID: 12091192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Catatonic dilemma in a schizoaffective patient with combined lithium-risperidone administration].
    Krähenmann R; Küchenhoff B; Böker H; Schick M
    Psychiatr Prax; 2010 Sep; 37(6):306-9. PubMed ID: 20803411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delirium and extrapyramidal symptoms due to a lithium-olanzapine combination therapy: a case report.
    Tuglu C; Erdogan E; Abay E
    J Korean Med Sci; 2005 Aug; 20(4):691-4. PubMed ID: 16100469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotic treatment in child and adolescent first-episode psychosis: a longitudinal naturalistic approach.
    Castro-Fornieles J; Parellada M; Soutullo CA; Baeza I; Gonzalez-Pinto A; Graell M; Paya B; Moreno D; de la Serna E; Arango C
    J Child Adolesc Psychopharmacol; 2008 Aug; 18(4):327-36. PubMed ID: 18759642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic malignant syndrome and risperidone: a case report.
    Bonwick RJ; Hopwood MJ; Morris PL
    Aust N Z J Psychiatry; 1996 Jun; 30(3):419-21. PubMed ID: 8839956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delirium associated with lithium-quetiapine combination.
    Miodownik C; Alkatnany A; Frolova K; Lerner V
    Clin Neuropharmacol; 2008; 31(3):176-9. PubMed ID: 18520985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acute catatonia: Questions, diagnosis and prognostics, and the place of atypical antipsychotics].
    Belaizi M; Yahia A; Mehssani J; Bouchikhi Idrissi ML; Bichra MZ
    Encephale; 2013 Jun; 39(3):224-31. PubMed ID: 23095594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroleptic malignant syndrome during a change from haloperidol to risperidone.
    Reeves RR; Mack JE; Torres RA
    Ann Pharmacother; 2001 Jun; 35(6):698-701. PubMed ID: 11408988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
    Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
    Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.